Propanc Biopharma, Inc. (PPCB) — Institutional Holders, Q2 2026
4 institutional investment managers reported a PPCB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $56.5K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PPCB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- JANE STREET GROUPAdded · +19,822 sh+$29.7K
- CITADEL ADVISORSNew · +12,090 sh+$18.1K
- Caitong International Asset Management , LtdNew · +2 sh+$3.00
Biggest sellers
- UBS Group AGSold out · -7,305 sh-$11.0K
- Marex Group plcSold out · -2,709 sh-$4.1K
- Virtu FinancialSold out · -1,630 sh-$2.4K
- Sassicaia Capital AdvisersSold out · -640 sh-$960.00
- XTX Topco LtdSold out · -484 sh-$726.00
PPCB 13F holders ranked 1–4 of 4
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 25,550 sh | 25,550 | $38.3K | 0.00% | -82.2% |
| 2 | CITADEL ADVISORS#2 · 12,090 sh | 12,090 | $18.1K | 0.00% | New |
| 3 | HRT FINANCIAL#3 · 10,242 sh | 10,242 | $15.00 | 0.00% | New |
| 4 | Caitong International Asset Management , Ltd#4 · 2 sh | 2 | $3.00 | 0.00% | New |
Funds that sold out of PPCB in Q2 2026 (5)
Held PPCB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| UBS Group AG7,305 sh | 7,305 | $19.4K |
| Marex Group plc2,709 sh | 2,709 | $7.2K |
| Virtu Financial1,630 sh | 1,630 | $4.0K |
| Sassicaia Capital Advisers640 sh | 640 | $1.7K |
| XTX Topco Ltd484 sh | 484 | $1.3K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.